PALVELLA THERAPEUTICS, INC. (PVLA) › Operating Cash FlowPALVELLA THERAPEUTICS, INC. (PVLA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: $49.75M2018: -$1.07M2019: -$52.47M2020: -$45.90M2021: -$7.66M2022: -$59.93M2023: -$13.70M2024: -$10.84M2025: -$25.01M-$25.01M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$25.01M-130.7%2024-$10.84M+20.9%2023-$13.70M+77.1%2022-$59.93M-682.4%2021-$7.66M+83.3%2020-$45.90M+12.5%2019-$52.47M-4821.9%2018-$1.07M-102.1%2017$49.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share